Antiviral therapy of recurrent hepatitis B infection after liver transplantation: A retrospective analysis of 200 liver transplants for hepatitis B related liver diseases;Therapie der rekurrenten hepatitis-B-infektion nach lebertransplantation: Eine retrospektive analyse von 200 lebertransplantationen aufgrund von hepatitis-B-assoziierten lebererkrankungen

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 9, 2000, Pages 773-783

  Seehofer, D ^a   Rayes, N ^a   Bechstein, W O ^a   Naumann, U ^a   Neuhaus, R ^a   Berg, T ^a   Hopf, U ^a   Langrehr, J M ^a   Steinmuller, T ^a   Platz, K P ^a   Muller, A R ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Famciclovir; Hepatitis B; Lamivudine; Liver transplantation; Reinfection; Retransplantation

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR; HEPATITIS B ANTIBODY; LAMIVUDINE; VIRUS DNA;

ARTICLE; DRUG EFFICACY; DRUG SENSITIVITY; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; RECURRENT INFECTION; REINFECTION; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS REPLICATION;

2-AMINOPURINE; ADULT; ANTIVIRAL AGENTS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENGLISH ABSTRACT; FEMALE; HEPATITIS B, CHRONIC; HUMAN; IMMUNIZATION, PASSIVE; INTERFERON ALFA-2A; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033788909     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7528     Document Type: Article

References (55)

1. EUROHEP consensus report on the management of liver transplantation for hepatitis B virus infection
2. Liver transplantation in European patients with the hepatitis surface antigen
3. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization
4. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients
5. Evolution of hepatitis B virus liver disease after hepatic repleacement
6. Fulminant hepatitis B virus recurrence after liver transplantation in two patients also infected with hepatitis delta virus
7. Hepatic histological findings after transplantation for chronic hepatitis B infection, including a unique pattern of fibrosing cholestatic hepatitis
8. Behandlung der chronischen virushepatitis B/D und der akuten und chronischen virus-hepatitis C
9. Effect of alpha-interferon treatment in patients with hepatitis B e-antigen positive chronic hepatitis B: A meta analysis
10. Follow up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon
11. Preliminary experience with α-2b-interferon therapy in viral hepatitis in allograft recipients
12. Interferon alpha for recurrent hepatitis B infection after liver transplantation
13. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft
14. Famciclovir, from the bench to the patient - A comprehensive review of preclinical data
15. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection
16. A preliminary trial of lamivudine for chronic hepatitis B infection
17. New nucleoside analogues for chronic hepatitis B
18. Drug therapy for chronic hepatitis B. antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy
19. Molecular basis for persistant hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
20. Hepatitis B virus DNA in peripheral mononuclear cells in chronic hepatitis B after HBsAg clearance
21. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
22. Identification and characterization of mutations in hepatitis B virus resistance to lamivudine
23. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis
24. Lamivudine treatment for acute hepatitis B after liver transplantation
25. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
26. Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation
27. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
28. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
29. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA positive (precore mutant) chronic hepatitis B
30. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
31. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
32. Lamivudine resistance in immunocompetent chronic hepatitis B: Incidence and patterns
33. The sequential occurence of viral mutations in a liver transplant recipient re-infected with hepatitis B: Hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss
34. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
35. Mutations in the hepatitis B virus polymerase gene that are associated with resistance to famciclovir and lamivudine
36. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
37. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance
38. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro
39. Antiviral chemotherapy for chronic hepatitis B infection: Lessons learned from treating HIV-infected patients
40. Combination therapy for chronic hepatitis B
41. Potential mechanisms for sustained antiretroviral efficacy of AZT-3TC combination therapy
42. Retransplantation in hepatitis B - A multicenter experience
43. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the first allograft
44. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: Durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin
45. Mutations in hepatitis B polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro
46. Efficacy of Thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
47. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro
48. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system
49. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation
50. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation
51. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
52. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low dose hepatitis B immune globulin
53. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation
54. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation
55. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation